P1586: IN-HOSPITAL MORTALITY AND POOR PROGNOSIS FACTORS ASSESSMENT IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND COVID-19. gan D. Ivanova, E. Baryakh, T. Tolstykh, T. Chudnova, Y. Polyakov, O. Kochneva, M. Litvinenko, E. Misyurina, K. Yatskov

Cael y testun llawn

P1612: ACUTE MYELOID LEUKEMIA IN ADULT PATIENTS: FEATURES OF TREATMENT IN CONTEXT OF THE COVID-19 PANDEMIC. gan T. Tolstykh, E. Baryakh, D. Ivanova, T. Chudnova, M. Misyurina, E. Medvedovskaya, M. Litvinenko, Y. Polyakov, O. Kochneva

Cael y testun llawn

PB2272: THERAPY AND HOSPITAL MORTALITY PREDICTORS IN HEMATOLOGICAL PATIENTS WITH 4 GRADE NEUTROPENIA AND CONCOMITANT CORONAVIRUS INFECTION gan K. Kaluzskaya, Y. Polyakov, E. Baryakh, E. Gemdzhian, E. Misyurina, E. Zhelnova, K. Yatskov, O. Kochneva, T. Chudnova

Cael y testun llawn

PB1870: COVID - 19 IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: HOSPITAL MORALITY PREDICTORS gan O. Kochneva, E. Baryakh, E. Misyurina, E. Zhelnova, K. Yatskov, Y. Polyakov, K. Kaluzhskaya, T. Chudnova, T. Tolstykh, D. Ivanova

Cael y testun llawn

P1574: ANTINEOPLASTIC THERAPY FOR HEMATOLOGIC MALIGNANCIES DURING COVID-19 gan T. Chudnova, E. Baryakh, Y. Polyakov, T. Tolstykh, O. Kochneva, D. Ivanova, E. Misyurina, K. Yatskov, E. Zhelnova, M. Litvinenko, K. Kaluzhskaya

Cael y testun llawn

P1599: THERAPY AND HOSPITAL MORTALITY PREDICTORS IN PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS AND CONCOMITANT COVID-19 INFECTION gan Y. Polyakov, K. Kaluzhskaya, E. Baryakh, E. Gemdzhian, E. Misyurina, E. Zhelnova, K. Yatskov, O. Kochneva, S. Andreev, T. Chudnova, D. Ivanova, T. Tolstykh

Cael y testun llawn

PB1853: IN-HOSPITAL SURVIVAL OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND CONCOMITANT CORONAVIRUS INFECTION DEPENDING ON VARIOUS CLINICAL FACTORS. gan E. Baryakh, E. Misyurina, E. Zhelnova, K. Yatskov, O. Kochneva, Y. Polyakov, D. Ivanova, K. Kaluzhskaya, T. Tolstykh, T. Chudnova, I. Samsonova, M. Lysenko

Cael y testun llawn